Amgen Inc. (IR)

About Amgen Inc.

Amgen Inc. is a leading biotechnology company dedicated to discovering, developing, and delivering innovative human therapeutics. Founded in 1980, the company has established itself as a pioneer in the field of biotechnology, focusing on areas such as oncology, nephrology, and inflammation. With a commitment to advancing science and improving patient outcomes, Amgen leverages its expertise in molecular biology and genetics to create groundbreaking therapies.

The company operates globally, with a significant presence in the UK, where it collaborates with healthcare professionals and institutions to address unmet medical needs. Amgen’s research and development efforts are driven by a passion for innovation, aiming to transform the lives of patients through cutting-edge treatments.

Amgen’s portfolio includes several blockbuster drugs that have revolutionised treatment protocols in various therapeutic areas. The company is also committed to sustainability and corporate responsibility, actively engaging in initiatives that promote environmental stewardship and community health.

• Core Values: Innovation, Integrity, and Patient-Centricity
• Vision: To be the world’s leading biotechnology company, providing solutions that enhance the quality of life for patients.
• Mission: To serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives.

With a workforce of over 20,000 employees worldwide, Amgen fosters a culture of collaboration and excellence. The company invests heavily in research and development, ensuring that it remains at the forefront of scientific advancements. As a trusted partner in healthcare, Amgen continues to strive for breakthroughs that will shape the future of medicine.